Studies on vaccination against papillomaviruses: Prophylactic and therapeutic vaccination with recombinant structural proteins

Virology

Volumn 184, Issue 1, 1991, Pages 33-42

  Jarrett, W F H ^a   Smith, K T ^b   O'Neil, B W ^a   Gaukroger, J M ^a   Chandrachud, L M ^a   Grindlay, G J ^b   McGarvie, G M ^b   Campo, M S ^b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT PROTEIN; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANTIVIRAL ACTIVITY; ARTICLE; CARCINOGENESIS; CATTLE; ESCHERICHIA COLI; HISTOLOGY; INTRAMUSCULAR DRUG ADMINISTRATION; NONHUMAN; PAPILLOMA VIRUS; PRIORITY JOURNAL; VACCINATION;

ANIMAL; BETA-GALACTOSIDASE; CATTLE; CLONING, MOLECULAR; ESCHERICHIA COLI; IMMUNIZATION; MALE; NEUTRALIZATION TESTS; PAPILLOMAVIRUS, BOVINE; RECOMBINANT FUSION PROTEINS; SUPPORT, NON-U.S. GOV'T; TUMOR VIRUS INFECTIONS; VIRAL PROTEINS; VIRAL VACCINES;

ANIMALIA; BOS TAURUS; BOVINE PAPILLOMAVIRUS TYPE 2; BOVINE PARVOVIRUS; ESCHERICHIA COLI; PAPILLOMAVIRUS;

EID: 0025880211     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/0042-6822(91)90819-W     Document Type: Article

References (31)

1. Molecular cloning of bovine papillomavirus genomes and comparison of their sequence homologies by heteroduplex mapping
2. Papillomavirus infection in cattle: Viral and chemical cofactors in naturally occurring and experimentally induced tumours
3. Molecular heterogeneity and lesion site specificity of cutaneous bovine papillomaviruses
4. Topographical and conformational epitopes of bovine papillomavirus type 1 defined by monoclonal antibodies
5. Papillomavirus genomes: Sequences and consequences
6. Mapping of linear epitopes of human papillomavirus type 16: The E 1, E2, E4, E5, E6, and E7 open reading frames
7. A quantitativein vitro focus forming assay for bovine papillomavirus
8. Antitumour immunity in the Shope papilloma-carcinoma complex of rabbits. I. Papilloma regression induced by homologous and autologous tissue vaccines
9. Immunogold silver staining: A new method of immunostaining with enhanced sensitivity
10. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques
11. Cooperation between bovine papillomavirus type 4 and ras in the morphological transformation of primary bovine fibroblasts
12. The natural history of bovine papillomavirus infection
13. Biological characteristics of bovine papillomaviruses
14. High incidence area of cattle cancer with a possible interaction between an environmental carcinogen and a papillomavirus
15. A novel bovine papillomavirus (BPV-6) causing true epithelial papillomas of the mammary gland skin: A member of a proposed new subgroup
16. Studies on vaccination against papillomaviruses: A comparison of purified virus, tumour extract and transformed cells in prophylactic vaccination
17. Studies on vaccination against papillomaviruses: The immunity after infection and vaccination with bovine papillomaviruses of different types
18. Identification of immunoreactive antigens of human papillomavirus type 6b by usingEscherichia coli-expressed fusion proteins
19. Identification of L2 open reading frame gene products of bovine papillomavirus type 1 using monoclonal antibodies
20. Bovine serological response to a recombinant BPV-1 major capsidprotein vaccine
21. Antibodies against the human papillomavirus type 16 early proteins in human sera: Correlation of anti-E7 reactivity with cervical cancer
22. Morphological transformation in vivo of human uterine cervix with papillomavirus from condylomata acuminata
23. Immunization against Human Papillomavirus type 16 tumour cells with recombinant vaccinia viruses expressing E6 and E7
24. Immunization against bovine papillomavirus infection
25. Nucleotide sequence of bovine papillomavirus type 2 late region
26. Easy identification of cDNA clones
27. Laryngeal papillomas
28. Human T-cell responses to human papillomavirus type 16 Ll and E6 synthetic peptides: Identification of T-cell determinants, HLA-DR restriction and virus type specificity
29. Identification of B epitopes in human papillomavirus type 16 E7 open reading frame protein
30. The induction of cytotoxic T-lymphocyte precursor cells by recombinant vaccinia virus expressing human papillomavirus type 16 L1
31. Condyloma acuminata and human genital cancer